Tradestie Institutional Equity Comparison Engine

STRO vs EQ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Growth & Margin, Options & Structure while STRO counters with relative strength in Momentum & Technical. Fundamentally, STRO trades at 10.0x Forward P/E with -254.7% operating margin (-6.1% YoY revenue) versus EQ at 1.5x Forward P/E and 0.0% operating margin (-52.3% YoY). In options structure, STRO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
STRO 10.0x vs EQ 1.5x Fwd P/E
Growth & Margin Winner EQ
Op Margin -254.7% vs 0.0% ยท YoY -6.1% vs -52.3%
Momentum & Technical Winner STRO
1Y +879.8% vs +12.0% ยท 52W Pos 18% vs 11%
Options & Structure Winner EQ
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (100th %ile IV)
STRO NASDAQ
Sutro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
$8.72
+2.59% 1D
Market Cap $141.1M
1M Return -19.18%
1Y Return +879.78%
Forward P/E 10.0x
Unified AI Score
54.9 / 100 HOLD
Tech 65.0 Fund 51.0 Flow 50.0 Mom 68.9
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STRO +879.78% EQ +12.0% Spread: +867.78 pp (STRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
STRO TTM Op. Margin: -254.7% EQ TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STRO vs EQ. Trailing 12-month operating profitability (STRO -254.7% vs EQ 0.0%) and valuation multiples (STRO 10.0x vs EQ 1.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STRO (5) vs EQ (4)
Institutional Metric STRO EQ Criterion Row Winner
Market Capitalization Scale $141.1M $90.6M Larger Scale STRO
Trailing P/E Ratio Valuation 10.0x 1.5x Lower Multiple EQ
Forward P/E Ratio Valuation 10.0x 1.5x Lower Multiple EQ
Revenue Growth (YoY) Growth -6.1% -52.3% Higher Growth STRO
Operating Margin (TTM) Profitability -254.7% 0.0% Higher Margin EQ
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1810.0% -59.0% Higher ROE EQ
52-Week Range Position Momentum 18% ($1โ€“$44) 11% ($1โ€“$4) Stronger Trend STRO
Beta / 30D Volatility Risk Regime 1.58ฮฒ ยท 77% Vol 1.53ฮฒ ยท 93% Vol Lower Realized Risk STRO
Unified Institutional Score Composite Signal 54.9 / 100 (HOLD) 48.0 / 100 (HOLD) Higher Composite STRO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STRO vs EQ Buy Guide
STRO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live STRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STRO nor EQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.